{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:14:03Z","timestamp":1790201643873,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100030692","name":"Intramural Research Program, National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["1R15DA049195-01A1"],"award-info":[{"award-number":["1R15DA049195-01A1"]}],"id":[{"id":"10.13039\/100030692","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["U54 GM104944"],"award-info":[{"award-number":["U54 GM104944"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Behav Health Serv Res"],"DOI":"10.1007\/s11414-026-09998-y","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:40:26Z","timestamp":1790199626000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinician-Level Variation in MAUD Prescribing: The Role of Behavioral Health Experience"],"prefix":"10.1007","author":[{"given":"Sarah A.","family":"Friedman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lex","family":"Owen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lung-Chang","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Woodard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle S.","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"9998_CR1","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th Edition: DSM-5. 5 edition. American Psychiatric Publishing; 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"9998_CR2","unstructured":"National Institute on Alcohol Abuse and Acoholism (NIAAA). Alcohol Use Disorder (AUD) in the United States: Age Groups and Demographic Characteristics. September 2024. Available at https:\/\/www.niaaa.nih.gov\/alcohols-effects-health\/alcohol-topics\/alcohol-facts-and-statistics\/alcohol-use-disorder-aud-united-states-age-groups-and-demographic-characteristics. Accessed June 6, 2025."},{"issue":"2","key":"9998_CR3","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1001\/jama.2021.7683","volume":"326","author":"AK Singal","year":"2021","unstructured":"Singal AK, Mathurin P. Diagnosis and Treatment of Alcohol-Associated Liver Disease: A Review. JAMA. 2021;326(2):165\u2013176. https:\/\/doi.org\/10.1001\/jama.2021.7683","journal-title":"JAMA."},{"issue":"9","key":"9998_CR4","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1111\/add.14703","volume":"114","author":"E Day","year":"2019","unstructured":"Day E, Rudd JHF. Alcohol use disorders and the heart. Addiction. 2019;114(9):1670\u20131678. https:\/\/doi.org\/10.1111\/add.14703","journal-title":"Addiction."},{"issue":"10","key":"9998_CR5","doi-asserted-by":"publisher","first-page":"3419","DOI":"10.3390\/nu13103419","volume":"13","author":"M Roerecke","year":"2021","unstructured":"Roerecke M. Alcohol\u2019s Impact on the Cardiovascular System. Nutrients. 2021;13(10):3419. https:\/\/doi.org\/10.3390\/nu13103419","journal-title":"Nutrients."},{"issue":"3","key":"9998_CR6","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/bjc.2014.579","volume":"112","author":"V Bagnardi","year":"2015","unstructured":"Bagnardi V, Rota M, Botteri E, et al. Alcohol consumption and site-specific cancer risk: a comprehensive dose-response meta-analysis. British Journal of Cancer. 2015;112(3):580-593. https:\/\/doi.org\/10.1038\/bjc.2014.579","journal-title":"British Journal of Cancer."},{"key":"9998_CR7","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.alcohol.2017.07.008","volume":"65","author":"M Subramaniam","year":"2017","unstructured":"Subramaniam M, Mahesh MV, Peh CX, et al. Hazardous alcohol use among patients with schizophrenia and depression. Alcohol. 2017;65:63\u201369. https:\/\/doi.org\/10.1016\/j.alcohol.2017.07.008","journal-title":"Alcohol."},{"issue":"10","key":"9998_CR8","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1111\/j.1530-0277.2012.01785.x","volume":"36","author":"B Taylor","year":"2012","unstructured":"Taylor B, Rehm J. The relationship between alcohol consumption and fatal motor vehicle injury: high risk at low alcohol levels. Alcohol Clinical and Experimental Research. 2012;36(10):1827\u20131834. https:\/\/doi.org\/10.1111\/j.1530-0277.2012.01785.x","journal-title":"Alcohol Clinical and Experimental Research."},{"issue":"1","key":"9998_CR9","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1176\/appi.ajp.2017.1750101","volume":"175","author":"VI Reus","year":"2018","unstructured":"Reus VI, Fochtmann LJ, Bukstein O, et al. The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder. American Journal of Psychiatry. 2018;175(1):86\u201390. https:\/\/doi.org\/10.1176\/appi.ajp.2017.1750101","journal-title":"American Journal of Psychiatry."},{"key":"9998_CR10","unstructured":"Substance Abuse and Mental Health Services Administration and National Institute on Alcohol Abuse and Alcoholism. Medication for the Treatment of Alcohol Use Disorder: A Brief Guide. Substance Abuse and Mental Health Services Administration; 2015. Available at https:\/\/store.samhsa.gov\/sites\/default\/files\/d7\/priv\/sma15-4907.pdf. Accessed February 16, 2025."},{"key":"9998_CR11","unstructured":"American Society of Addiction Medicine. Clinical Practice Guideline on Alcohol Withdrawal Management. 2020. Available at https:\/\/www.asam.org\/docs\/default-source\/quality-science\/the_asam_clinical_practice_guideline_on_alcohol-1.pdf?sfvrsn=ba255c2_2. Accessed February 1, 2025."},{"key":"9998_CR12","unstructured":"Substance Abuse and Mental Health Services Administration. 2024\u202fNational Survey on Drug Use and Health. Table 5.21A\u202f\u2013 Received medication-assisted treatment (MAT) for alcohol use in past year: among people aged 12 and older; received MAT\u202ffor alcohol use in past year: among people aged 12 and older\u202fwith past year alcohol use disorder; by demographic characteristics, numbers in thousands, 2023\u202fand 2024. Center for Behavioral Health Statistics and Quality. August 2025. Available at https:\/\/www.samhsa.gov\/data\/report\/2024-nsduh-detailed-tables. Accessed January 25, 2026."},{"key":"9998_CR13","unstructured":"Substance Abuse and Mental Health Services Administration. 2024\u202fNational Survey on Drug Use and Health. Table 5.21B\u202f\u2013 Received medication-assisted treatment (MAT) for alcohol use in past year: among people aged 12 and older; received MAT\u202ffor alcohol use in past year: among people aged 12 and older\u202fwith past year alcohol use disorder; by demographic characteristics, Percentages,, 2023\u202fand 2024. Center for Behavioral Health Statistics and Quality. August 2025. Available at https:\/\/www.samhsa.gov\/data\/report\/2024-nsduh-detailed-tables. Accessed January 25, 2026."},{"key":"9998_CR14","unstructured":"SUD Treatment in Medicaid: Variation by Service Type, Demographics, States and Spending. San Francisco, California: Kaiser Family Foundation, 2024. Available at https:\/\/www.kff.org\/mental-health\/sud-treatment-in-medicaid-variation-by-service-type-demographics-states-and-spending\/. Accessed January 27, 2026."},{"issue":"3","key":"9998_CR15","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.0695","volume":"8","author":"MT Stewart","year":"2025","unstructured":"Stewart MT, Feltus SR, Andrews CM, et al. Alcohol Use Disorder Medication Coverage and Utilization Management in Medicaid Managed Care Plans. JAMA Network Open. 2025;8(3):e250695. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.0695","journal-title":"JAMA Network Open."},{"key":"9998_CR16","unstructured":"Medicaid Enrollees are Sicker and More Disabled than the Privately-Insured. San Francisco, California: Kaiser Family Foundation, 2013. Available at https:\/\/www.kff.org\/medicaid\/medicaid-enrollees-are-sicker-and-more-disabled-than-the-privately-insured\/. Accessed February 15, 2026."},{"key":"9998_CR17","unstructured":"Saunders H. A Look at Substance Use Disorders (SUD) Among Medicaid Enrollees. San Francisco, California: Kaiser Family Foundation, 2023. Available at https:\/\/www.kff.org\/mental-health\/issue-brief\/a-look-at-substance-use-disorders-sud-among-medicaid-enrollees\/. Accessed December 16, 2024."},{"issue":"9","key":"9998_CR18","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1377\/hlthaff.2025.00343","volume":"44","author":"S Crystal","year":"2025","unstructured":"Crystal S, Xie F, Samples H, et al. States With Substantial Increases In Buprenorphine Uptake Did So With Increased Medicaid Prescribing, 2018\u201324. Health Affairs (Millwood). 2025;44(9):1102\u20131111. https:\/\/doi.org\/10.1377\/hlthaff.2025.00343","journal-title":"Health Affairs (Millwood)."},{"issue":"4","key":"9998_CR19","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1370\/afm.2997","volume":"21","author":"A Bhardwaj","year":"2023","unstructured":"Bhardwaj A, Sousa JL, Huskamp HA, et al. Prescribing Medications for Alcohol Use Disorder: A Qualitative Study of Primary Care Physician Decision Making. Annals of Family Medicine. 2023;21(4):332\u2013337. https:\/\/doi.org\/10.1370\/afm.2997","journal-title":"Annals of Family Medicine."},{"issue":"5","key":"9998_CR20","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1046\/j.1360-0443.2003.00377.x","volume":"98","author":"TL Mark","year":"2003","unstructured":"Mark TL, Kranzler HR, Song X, Bransberger P, Poole VH, Crosse S. Physicians\u2019 opinions about medications to treat alcoholism. Addiction. 2003;98(5):617\u2013626. https:\/\/doi.org\/10.1046\/j.1360-0443.2003.00377.x","journal-title":"Addiction."},{"issue":"4","key":"9998_CR21","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1037\/a0030949","volume":"10","author":"AHS Harris","year":"2013","unstructured":"Harris AHS, Ellerbe L, Reeder RN, et al. Pharmacotherapy for alcohol dependence: perceived treatment barriers and action strategies among Veterans Health Administration service providers. Psychology Services. 2013;10(4):410\u2013419. https:\/\/doi.org\/10.1037\/a0030949","journal-title":"Psychology Services."},{"key":"9998_CR22","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jsat.2015.10.005","volume":"62","author":"HK Knudsen","year":"2016","unstructured":"Knudsen HK, Roman PM. The Diffusion of Acamprosate for the Treatment of Alcohol Use Disorder: Results From a National Longitudinal Study. Journal of Substance Use and Addiction Treatment. 2016;62:62\u201367. https:\/\/doi.org\/10.1016\/j.jsat.2015.10.005","journal-title":"Journal of Substance Use and Addiction Treatment."},{"issue":"3","key":"9998_CR23","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.amepre.2024.11.006","volume":"68","author":"A Kennedy-Hendricks","year":"2025","unstructured":"Kennedy-Hendricks A, Busch AB, Azeni H, et al. Clinician Prescribing Practices Involving Medications for Alcohol Use Disorder. American Journal of Preventive Medicine. 2025;68(3):446\u2013454. https:\/\/doi.org\/10.1016\/j.amepre.2024.11.006","journal-title":"American Journal of Preventive Medicine."},{"key":"9998_CR24","unstructured":"Packham J, Griswold T, Mwalili N, Brown A, Etchegoyhen L. Health Workforce in Nevada: A Chartbook. Reno, NV: Nevada Health Workforce Research Center, Office of Statewide Initiatives, School of Medicine, University of Nevada Reno, 2023. Available at https:\/\/gowinn.nv.gov\/wp-content\/uploads\/2023\/12\/23-HWIN-Chartbook-Final-May-2023.pdf. Accessed February 20, 2025."},{"issue":"7624","key":"9998_CR25","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","volume":"335","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies. British Medical Journal. 2007;335(7624):806\u2013808. https:\/\/doi.org\/10.1136\/bmj.39335.541782.AD","journal-title":"British Medical Journal."},{"issue":"5","key":"9998_CR26","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1370\/afm.2854","volume":"20","author":"AN Huffstetler","year":"2022","unstructured":"Huffstetler AN, Sabo RT, Lavallee M, et al. Using State All-Payer Claims Data to Identify the Active Primary Care Workforce: A Novel Study in Virginia. Annals of Family Medicine. 2022;20(5):446\u2013451. https:\/\/doi.org\/10.1370\/afm.2854","journal-title":"Annals of Family Medicine."},{"key":"9998_CR27","unstructured":"National Plan and Provider Enumeration System (NPPES). Baltimore, Maryland: Centers for Medicare and Medicaid Services, 2024. Available at https:\/\/npiregistry.cms.hhs.gov\/search. Accessed December 2, 2024."},{"key":"9998_CR28","doi-asserted-by":"publisher","unstructured":"Glez-Pe\u00f1a D, Louren\u00e7o A, L\u00f3pez-Fern\u00e1ndez H, et al. Web scraping technologies in an API world. Briefings in Bioinformatics. 2014;5(15). https:\/\/doi.org\/10.1093\/bib\/bbt026","DOI":"10.1093\/bib\/bbt026"},{"key":"9998_CR29","unstructured":"Mitchell R. Web Scraping with Python: Collecting More Data from the Modern Web. O\u2019Reilly Media, Inc.; 2018."},{"key":"9998_CR30","doi-asserted-by":"publisher","unstructured":"Wen H, Hockenberry JM, Pollack HA. Association of Buprenorphine-Waivered Physician Supply With Buprenorphine Treatment Use and Prescription Opioid Use in Medicaid Enrollees. JAMA Network Open. 2018;1(5). https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.2943","DOI":"10.1001\/jamanetworkopen.2018.2943"},{"issue":"4","key":"9998_CR31","doi-asserted-by":"publisher","first-page":"e230221","DOI":"10.1001\/jamahealthforum.2023.0221","volume":"4","author":"TB Creedon","year":"2023","unstructured":"Creedon TB, Ali MM, Schuman-Olivier Z. Trends in Buprenorphine Prescribing for Opioid Use Disorder by Psychiatrists in the US From 2003 to 2021. JAMA Health Forum. 2023;4(4):e230221\u2013e230221. https:\/\/doi.org\/10.1001\/jamahealthforum.2023.0221","journal-title":"JAMA Health Forum."},{"key":"9998_CR32","unstructured":"U.S. Department of Health and Human Services. Many Medicaid Enrollees with Opioid Use Disorder Were Treated with Medication; However, Disparities Present Concerns. Office of Inspector General, Publication number OEI-BL-22\u201300260, 2023. Available at https:\/\/oig.hhs.gov\/oei\/reports\/moud-one-pager.pdf. Accessed January 5, 2024."},{"key":"9998_CR33","unstructured":"Hilbe J. Negative Binomial Regression. Cambridge, UK: Cambridge University Press, 2012. Available at http:\/\/works.bepress.com\/joseph_hilbe\/16. Accessed August 12, 2014."},{"key":"9998_CR34","doi-asserted-by":"crossref","unstructured":"Cameron AC, Trivedi PK. Regression Analysis of Count Data. 2 edition. Cambridge University Press; 2013.","DOI":"10.1017\/CBO9781139013567"},{"key":"9998_CR35","unstructured":"How can I analyze count data in Stata? | Stata FAQ. 2024. Los Angeles, California: Office of Advanced Research Computing (OARC), 2024. Available at https:\/\/stats.oarc.ucla.edu\/stata\/faq\/how-can-i-analyze-count-data-in-stata\/. Accessed March 26, 2025."},{"key":"9998_CR36","unstructured":"America\u2019s Health Rankings. Explore Excessive Drinking in Nevada. Eden Prairie, MN: United Health Foundation. Available at https:\/\/www.americashealthrankings.org\/explore\/measures\/ExcessDrink\/NV. Accessed March 11, 2025."},{"issue":"4","key":"9998_CR37","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1093\/alcalc\/agv127","volume":"51","author":"J Rehm","year":"2016","unstructured":"Rehm J, Anderson P, Manthey J, et al. Alcohol Use Disorders in Primary Health Care: What Do We Know and Where Do We Go? Alcohol and Alcoholism. 2016;51(4):422\u2013427. https:\/\/doi.org\/10.1093\/alcalc\/agv127","journal-title":"Alcohol and Alcoholism."},{"key":"9998_CR38","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jsat.2020.02.008","volume":"112S","author":"KA Stephens","year":"2020","unstructured":"Stephens KA, West II, Hallgren KA, et al. Service utilization and chronic condition outcomes among primary care patients with substance use disorders and co-occurring chronic conditions. Journal of Substance Use and Addiction Treatment. 2020;112S:49\u201355. https:\/\/doi.org\/10.1016\/j.jsat.2020.02.008","journal-title":"Journal of Substance Use and Addiction Treatment."},{"issue":"2","key":"9998_CR39","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1093\/fampra\/cmab095","volume":"39","author":"DM O\u2019Malley","year":"2022","unstructured":"O\u2019Malley DM, Abraham CM, Lee HS, et al. Substance use disorder approaches in US primary care clinics with national reputations as workforce innovators. Family Practice. 2022;39(2):282\u2013291. https:\/\/doi.org\/10.1093\/fampra\/cmab095","journal-title":"Family Practice."},{"issue":"1","key":"9998_CR40","doi-asserted-by":"publisher","DOI":"10.2196\/13252","volume":"22","author":"CS Kruse","year":"2020","unstructured":"Kruse CS, Lee K, Watson JB, Lobo LG, Stoppelmoor AG, Oyibo SE. Measures of Effectiveness, Efficiency, and Quality of Telemedicine in the Management of Alcohol Abuse, Addiction, and Rehabilitation: Systematic Review. Journal of Medical Internet Research. 2020;22(1):e13252. https:\/\/doi.org\/10.2196\/13252","journal-title":"Journal of Medical Internet Research."},{"key":"9998_CR41","doi-asserted-by":"publisher","unstructured":"Busch AB, Greenfield SF, Huskamp HA. Expanding Alcohol Use Disorder Medications in Primary Care. JAMA Internal Medicine. Published online March 3, 2025. https:\/\/doi.org\/10.1001\/jamainternmed.2024.8325","DOI":"10.1001\/jamainternmed.2024.8325"},{"issue":"1","key":"9998_CR42","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1093\/alcalc\/agac057","volume":"58","author":"EY Bernstein","year":"2023","unstructured":"Bernstein EY, Pfoh ER, Le P, Rothberg MB. Relationship Between Primary Care Providers\u2019 Perceptions of Alcohol Use Disorder And Pharmacotherapy Prescribing Rates. Alcohol and Alcoholism. 2023;58(1):54\u201359. https:\/\/doi.org\/10.1093\/alcalc\/agac057","journal-title":"Alcohol and Alcoholism."},{"issue":"1","key":"9998_CR43","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1360-0443.2004.00597.x","volume":"99","author":"RK Fuller","year":"2004","unstructured":"Fuller RK, Gordis E. Does disulfiram have a role in alcoholism treatment today? Addiction. 2004;99(1):21-24. https:\/\/doi.org\/10.1111\/j.1360-0443.2004.00597.x","journal-title":"Addiction."},{"key":"9998_CR44","unstructured":"Center for Substance Abuse Treatment. Incorporating Alcohol Pharmacotherapies Into Medical Practice. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2009. (Treatment Improvement Protocol (TIP) Series, No. 49.) Chapter 3\u2014Disulfiram.\u00a0Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK64036\/. Accessed January 15, 2026."},{"issue":"6","key":"9998_CR45","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1097\/ADM.0000000000001360","volume":"18","author":"Sarah Axelrath","year":"2024","unstructured":"Axelrath, Sarah. Disulfiram Should Remain Second-Line Treatment for Most Patients With Alcohol Use Disorder. Journal of Addiction Medicine 2024;18 (6): 617\u201318. https:\/\/doi.org\/10.1097\/ADM.0000000000001360.","journal-title":"Journal of Addiction Medicine"}],"container-title":["The Journal of Behavioral Health Services & Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11414-026-09998-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11414-026-09998-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11414-026-09998-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:40:31Z","timestamp":1790199631000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11414-026-09998-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":45,"alternative-id":["9998"],"URL":"https:\/\/doi.org\/10.1007\/s11414-026-09998-y","relation":{},"ISSN":["1094-3412","1556-3308"],"issn-type":[{"value":"1094-3412","type":"print"},{"value":"1556-3308","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]},"assertion":[{"value":"17 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The University of Nevada, Reno\u2019s Office of Research Integrity, has reviewed this project and determined that, because the data are deidentified, it does not qualify as human research and thus does not require oversight by the Institutional Review Board.","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Sarah Friedman: no conflicts of interest; Ying Guo: no conflicts of interest; Lex Owen: no conflicts of interest; Lung-Chang Chien: no conflicts of interest; Stephanie Woodard: no conflicts of interest; Michelle Keller: Dr. Keller provides scientific advising to an AI Healthcare Company and owns equity in the company.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"STROBE for cross-sectional studies.","order":3,"name":"Ethics","label":"Reporting Guidelines","group":{"name":"EthicsHeading","label":"Declarations"}}]}}